Erik R Dubberke MD
Assistant Professor, Internal Medicine, Washington University School of Medicine
Join to view full profile
620 S Taylor Ave# DvSt. Louis, MO 63110
Phone+1 314-362-9098
Fax+1 314-362-9851
Dr. Dubberke is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Washington University/B-JH/SLCH ConsortiumFellowship, Infectious Disease, 2002 - 2004- Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 1999 - 2002
University of Illinois College of MedicineClass of 1999
Certifications & Licensure
MO State Medical License 2000 - 2027
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification Allscripts TouchWorks EHR, Allscripts, 2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification Allscripts TouchWorks EHR (Complete), Allscripts, 2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2014, 2016-2017
Clinical Trials
- Autologous Fecal Therapy
- Fecal Microbiota Transplantation (FMT) for MDRO UTI Start of enrollment: 2018 Feb 08
- TOX NEG Trial: Clostridium Difficile Diagnosis and Treatment Start of enrollment: 2017 Dec 29
Publications & Presentations
PubMed
- 1 citationsColonization and Infection in Pediatric Oncology and Stem Cell Transplant Patients.Daniel N Willis, Erik R Dubberke, Robert J Hayashi, Phillip I Tarr, David B Haslam
Open Forum Infectious Diseases. 2026-04-01 - 1 citationsRelationship BetweenStool Concentration, Nucleic Acid Amplification Test Results, and Environmental Contamination.Mary Morgan Lee, Kimberly A Reske, Tiffany Hink, Skye R S Fishbein, Erin P Newcomer
Open Forum Infectious Diseases. 2026-04-01 - Community-associated quinolone-resistant and extended-spectrum beta-lactamase-producingisolates are similar to clinical infection isolates by sequence type and resistome.Emily E Benedict, Wesley Agee, Tiffany Hink, Katelyn L Parrish, Kimberly A Reske
Msystems. 2026-02-17
Press Mentions
Theriva Biologics Announces Presentation of Data from Cohort 1 of the Phase 1b/2a Clinical Trial of SYN-004 (Ribaxamase) in Allogeneic Hematopoietic Cell Transplant RecipientsApril 13th, 2023
Synthetic Biologics Reports Second Quarter 2019 Operational Highlights and Financial ResultsNovember 4th, 2019
Gut Makeup Could Make Diarrhea Less LikelyAugust 16th, 2019
Grant Support
- Multi-Omics Unit for Combating Antibiotic-Resistant Bacteria (MOCARB)WASHINGTON UNIVERSITY2026–2031
- Phase 1b/2a Evaluation of the Safety and Tolerability of SYN-004 in Adult Allogeneic Hematopoietic Cell Transplantation (allo-HCT) RecipientsWASHINGTON UNIVERSITY2026–2031
- High-resolution genomic interrogation of pathogen-microbiome interactions in Clostridioides difficile infectionWASHINGTON UNIVERSITY2024–2029
- Culturomic and metagenomic methods optimization to detect multi-strain C. difficile colonization and infectionWASHINGTON UNIVERSITY2025–2027
- C. Difficile Disease In Stem Cell Transplant RecipientsNational Institute Of Allergy And Infectious Diseases2009–2011
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
